Resteghini C - Search Results

1

Head and neck cancers survival in Europe, Taiwan, and Japan: results from RARECAREnet Asia based on a privacy-preserving federated infrastructure.

Botta L, Matsuda T, Charvat H, Chiang CJ, Lee WC, van Gestel AJ, Martin F, Geleijnse G, Cellamare M, Bonfarnuzzo S, Marcos-Gragera R, Guevara M, Mousavi M, Craig S, Rodrigues J, Rubió-Casadevall J, Licitra L, Cavalieri S, Resteghini C, Gatta G, Trama A; RARECAREnet working group. Botta L, et al. Among authors: resteghini c. Front Oncol. 2023 Sep 13;13:1219111. doi: 10.3389/fonc.2023.1219111. eCollection 2023. Front Oncol. 2023. PMID: 37781187 Free PMC article.

2

Fentanyl pectin nasal spray as treatment for incident predictable breakthrough pain (BTP) in oral mucositis induced by chemoradiotherapy in head and neck cancer.

Bossi P, Locati L, Bergamini C, Mirabile A, Granata R, Imbimbo M, Resteghini C, Licitra L. Bossi P, et al. Among authors: resteghini c. Oral Oncol. 2014 Sep;50(9):884-7. doi: 10.1016/j.oraloncology.2014.06.013. Epub 2014 Jul 4. Oral Oncol. 2014. PMID: 25001894

3

Health care-associated infections in patients with head and neck cancer treated with chemotherapy and/or radiotherapy.

Mirabile A, Vismara C, Crippa F, Bossi P, Locati L, Bergamini C, Granata R, Resteghini C, Conte E, Morelli D, Scarpellini P, Licitra L. Mirabile A, et al. Among authors: resteghini c. Head Neck. 2016 Apr;38 Suppl 1:E1009-13. doi: 10.1002/hed.24147. Epub 2015 Oct 5. Head Neck. 2016. PMID: 26041138

4

Does a multidisciplinary team approach in a tertiary referral centre impact on the initial management of head and neck cancer?

Bergamini C, Locati L, Bossi P, Granata R, Alfieri S, Resteghini C, Imbimbo M, Fallai C, Orlandi E, Tana S, Iacovelli NA, Guzzo M, Ibba T, Colombo S, Bianchi R, Pizzi N, Fontanella W, Licitra L. Bergamini C, et al. Among authors: resteghini c. Oral Oncol. 2016 Mar;54:54-7. doi: 10.1016/j.oraloncology.2016.01.001. Epub 2016 Jan 13. Oral Oncol. 2016. PMID: 26774920

5

Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma.

Bossi P, Resteghini C, Paielli N, Licitra L, Pilotti S, Perrone F. Bossi P, et al. Among authors: resteghini c. Oncotarget. 2016 Nov 8;7(45):74362-74379. doi: 10.18632/oncotarget.11413. Oncotarget. 2016. PMID: 27556186 Free PMC article. Review.

6

Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy.

Bossi P, Bergamini C, Miceli R, Cova A, Orlandi E, Resteghini C, Locati L, Alfieri S, Imbimbo M, Granata R, Mariani L, Iacovelli NA, Huber V, Cavallo A, Licitra L, Rivoltini L. Bossi P, et al. Among authors: resteghini c. Int J Radiat Oncol Biol Phys. 2016 Dec 1;96(5):959-966. doi: 10.1016/j.ijrobp.2016.08.047. Epub 2016 Sep 6. Int J Radiat Oncol Biol Phys. 2016. PMID: 27745982

7

Systemic therapy in metastatic salivary gland carcinomas: A pathology-driven paradigm?

Alfieri S, Granata R, Bergamini C, Resteghini C, Bossi P, Licitra LF, Locati LD. Alfieri S, et al. Among authors: resteghini c. Oral Oncol. 2017 Mar;66:58-63. doi: 10.1016/j.oraloncology.2016.12.016. Epub 2017 Jan 19. Oral Oncol. 2017. PMID: 28249649 Review.

8

Outcome of recurrent and metastatic head and neck squamous cell cancer patients after first line platinum and cetuximab therapy.

Siano M, Infante G, Resteghini C, Cau MC, Alfieri S, Bergamini C, Granata R, Miceli R, Locati L, Licitra L, Bossi P. Siano M, et al. Among authors: resteghini c. Oral Oncol. 2017 Jun;69:33-37. doi: 10.1016/j.oraloncology.2017.04.002. Epub 2017 Apr 9. Oral Oncol. 2017. PMID: 28559018

9

Do not throw the baby out with the bathwater: SELECT a personalized, de-escalated lenvatinib schedule allows response in locally advanced DTC while controlling major drug-related bleeding.

Resteghini C, Locati LD, Bossi P, Bergamini C, Guzzo M, Licitra L. Resteghini C, et al. Ann Oncol. 2017 Sep 1;28(9):2321-2322. doi: 10.1093/annonc/mdx251. Ann Oncol. 2017. PMID: 28911079 Free article. No abstract available.

10

Management of tyrosine kinase inhibitors (TKI) side effects in differentiated and medullary thyroid cancer patients.

Resteghini C, Cavalieri S, Galbiati D, Granata R, Alfieri S, Bergamini C, Bossi P, Licitra L, Locati LD. Resteghini C, et al. Best Pract Res Clin Endocrinol Metab. 2017 Jun;31(3):349-361. doi: 10.1016/j.beem.2017.04.012. Epub 2017 May 10. Best Pract Res Clin Endocrinol Metab. 2017. PMID: 28911730 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters